From October 1, 2022 to December 31, 2022, the company has repurchased 430,700 shares, representing 1.15% for ¥1,442.97 million. With this, the company has completed the repurchase of 705,100 shares, representing 1.89% for ¥2,376.8 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,110 JPY | +1.97% | +2.64% | -4.89% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.89% | 691M | |
+47.70% | 765B | |
-6.73% | 354B | |
+19.44% | 331B | |
+8.90% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+4.61% | 164B | |
-2.59% | 162B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.